Mediately
Series A in 2022
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.
Mediately
Seed Round in 2019
Mediately is a prominent medical app company operating in Central and Eastern Europe and Italy, focusing on providing doctors with essential drug information, clinical decision support tools, and accredited medical education. The company serves eight countries: Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, where its applications are utilized by over 180,000 doctors and more than 200,000 healthcare professionals. Mediately's apps deliver high-quality, evidence-based information that enhances patient care, and they are certified as medical devices in the European Union. The platform offers immediate access to comprehensive medication details, including ingredients, pricing, interactions, dosing, and reimbursement, all in the local language of the users. Mediately is committed to maintaining high standards of quality management and adheres to the EN ISO 13485:2016 standard.